Showing 1 - 20 results of 31 for search 'Daniel J Weisdorf', query time: 0.07s Refine Results
  1. 1
    Survival for older patients with acute myeloid leukemia: a population-based study

    Survival for older patients with acute myeloid leukemia: a population-based study by Betul Oran, Daniel J. Weisdorf

    Published 2012-12-01
    Get full text
    Article
  2. 2
    A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics

    A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics by Armin Rashidi, Sathappan Karuppiah, Maryam Ebadi, Ryan Shanley, Alexander Khoruts, Daniel J. Weisdorf, Christopher Staley

    Published 2022-01-01
    Get full text
    Article
  3. 3
    A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics.

    A dose-finding safety and feasibility study of oral activated charcoal and its effects on the gut microbiota in healthy volunteers not receiving antibiotics. by Armin Rashidi, Sathappan Karuppiah, Maryam Ebadi, Ryan Shanley, Alexander Khoruts, Daniel J Weisdorf, Christopher Staley

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Validation of Minnesota acute graft-versus-host disease Risk Score

    Validation of Minnesota acute graft-versus-host disease Risk Score by Margaret L. MacMillan, Todd E. DeFor, Shernan G. Holtan, Armin Rashidi, Bruce R. Blazar, Daniel J. Weisdorf

    Published 2020-02-01
    Get full text
    Article
  5. 5
    75200 Fecal Microbiota Transplantation to Prevent Infections in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Placebo-Controlled Phase 2 Clinical Trial

    75200 Fecal Microbiota Transplantation to Prevent Infections in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Placebo-Controlled Phase 2 Clinical Trial by Armin Rashidiryam Ebadi, Tauseef Ur Rehman, Harika Nalluri, Thomas Kaiser, Shernan G. Holtan, Alexander Khoruts, Daniel J. Weisdorf, Christopher Staley

    Published 2021-03-01
    Get full text
    Article
  6. 6
    The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples

    The association of CMV with NK-cell reconstitution depends on graft source: results from BMT CTN-0201 samples by Armin Rashidi, Xianghua Luo, Sarah Cooley, Claudio Anasetti, Edmund K. Waller, Claudio G. Brunstein, Frank Cichocki, Daniel J. Weisdorf, Jeffrey S. Miller

    Published 2019-08-01
    Get full text
    Article
  7. 7
    Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium

    Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium by Joseph Pidala, Brenda F. Kurland, Xiaoyu Chai, Georgia Vogelsang, Daniel J. Weisdorf, Steven Pavletic, Corey Cutler, Navneet Majhail, Stephanie J. Lee

    Published 2011-10-01
    Get full text
    Article
  8. 8
    Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia

    Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia by Armin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, Heba Elhusseini, Hossam Halaweish, Thomas Kaiser, Shernan G. Holtan, Alexander Khoruts, Daniel J. Weisdorf, Christopher Staley

    Published 2022-08-01
    Get full text
    Article
  9. 9
    Loss of microbiota-derived protective metabolites after neutropenic fever

    Loss of microbiota-derived protective metabolites after neutropenic fever by Armin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, Heba Elhusseini, Hossam Halaweish, Shernan G. Holtan, Sivapriya Ramamoorthy, Daniel J. Weisdorf, Alexander Khoruts, Christopher Staley

    Published 2022-04-01
    Get full text
    Article
  10. 10
    Gut microbiota response to antibiotics is personalized and depends on baseline microbiota

    Gut microbiota response to antibiotics is personalized and depends on baseline microbiota by Armin Rashidi, Maryam Ebadi, Tauseef Ur Rehman, Heba Elhusseini, Harika Nalluri, Thomas Kaiser, Shernan G. Holtan, Alexander Khoruts, Daniel J. Weisdorf, Christopher Staley

    Published 2021-10-01
    Get full text
    Article
  11. 11
    HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis

    HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis by Mohamad A. Meybodi, Wenhao Cao, Leo Luznik, Asad Bashey, Xu Zhang, Rizwan Romee, Wael Saber, Mehdi Hamadani, Daniel J. Weisdorf, Haitao Chu, Armin Rashidi

    Published 2019-09-01
    Get full text
    Article
  12. 12
    Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy.

    Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy. by Armin Rashidi, Zhigang Zhu, Thomas Kaiser, Dawn A Manias, Shernan G Holtan, Tauseef Ur Rehman, Daniel J Weisdorf, Alexander Khoruts, Gary M Dunny, Christopher Staley

    Published 2019-01-01
    Get full text
    Article
  13. 13
    Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study

    Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-... by Joseph Pidala, Georgia Vogelsang, Paul Martin, Xiaoyu Chai, Barry Storer, Steven Pavletic, Daniel J. Weisdorf, Madan Jagasia, Corey Cutler, Jeanne Palmer, David Jacobsohn, Sally Arai, Stephanie J. Lee

    Published 2012-03-01
    Get full text
    Article
  14. 14
    Amphiregulin as a biomarker for monitoring lifethreatening acute graft-<i>versus</i>-host disease: secondary analysis of two prospective clinical trials

    Amphiregulin as a biomarker for monitoring lifethreatening acute graft-<i>versus</i>-host disease: secondary analysis of two prospective clinical trials by Shernan G. Holtan, Najla El Jurdi, Armin Rashidi, Brian C. Betts, Connor Demorest, John P Galvin, Margaret L. MacMillan, Daniel J. Weisdorf, Angela Panoskaltsis-Mortari, Michael A. Pratta

    Published 2023-09-01
    Get full text
    Article
  15. 15
    Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD

    Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD by Craig E. Eckfeldt, Nicole Randall, Ryan M. Shanley, Sophia Yohe, Nelli Bejanyan, Michelle Dolan, Erica D. Warlick, Michael R. Verneris, Claudio G. Brunstein, John E. Wagner, Daniel J. Weisdorf, Celalettin Ustun

    Published 2016-08-01
    Get full text
    Article
  16. 16
    161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS

    161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS by Dhifaf Sarhan, Ludwig Brandt, Martin Felices, Karolin Guldevall, Todd Lenvik, Peter Hinderlie, Julie Curtsinger, Erica Warlick, Stephen R. Spellman, Bruce R. Blazar, Daniel J. Weisdorf, Sarah Cooley, Daniel A. Vallera, Björn Önfelt, Jeffrey S. Miller

    Published 2018-06-01
    Get full text
    Article
  17. 17
    Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation.

    Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation. by Armin Rashidi, Maryam Ebadi, Robin R Shields-Cutler, Kathryn Kruziki, Dawn A Manias, Aaron M T Barnes, Todd E DeFor, Patricia Ferrieri, Jo-Anne H Young, Dan Knights, Bruce R Blazar, Daniel J Weisdorf, Gary M Dunny

    Published 2019-01-01
    Get full text
    Article
  18. 18
    Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease

    Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease by Yoshihiro Inamoto, Paul J. Martin, Barry E. Storer, Jeanne Palmer, Daniel J. Weisdorf, Joseph Pidala, Mary E. D. Flowers, Mukta Arora, Madan Jagasia, Sally Arai, Xiaoyu Chai, Steven Z. Pavletic, Georgia B. Vogelsang, Stephanie J. Lee

    Published 2014-10-01
    Get full text
    Article
  19. 19
    First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia

    First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia by Sarah Cooley, Fiona He, Veronika Bachanova, Gregory M. Vercellotti, Todd E. DeFor, Julie M. Curtsinger, Paul Robertson, Bartosz Grzywacz, Kevin C. Conlon, Thomas A. Waldmann, David H. McKenna, Bruce R. Blazar, Daniel J. Weisdorf, Jeffrey S. Miller

    Published 2019-07-01
    Get full text
    Article
  20. 20
    Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

    Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics by Fatma Keklik, Ezzideen Barjes Alrawi, Qing Cao, Nelli Bejanyan, Armin Rashidi, Aleksandr Lazaryan, Patrick Arndt, Erhan H. Dincer, Veronika Bachanova, Erica D. Warlick, Margaret L. MacMillan, Mukta Arora, Jeffrey Miller, Claudio G Brunstein, Daniel J. Weisdorf, Celalettin Ustun

    Published 2018-12-01
    Get full text
    Article

Search Tools: